Stock Detail
CORCEPT THERAPEUTICS INCORPORATED
CORT @ Yahoo Finance | CORT Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $3.35 | $3.53 | $-0.10 | -2.90% | 0.00 | $3.45 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $3.40 | $3.35 | 108,183 | 282.17M | 161,716 | -9.05 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 3.59 | 3.47 | 3.41 | 3.29 | 3.23 |
Stock Profile
Corcept Therapeutics Incorporated, a development stage biopharmaceutical company, engages in the development of drugs for the treatment of severe psychiatric and neurological diseases. The company develops CORLUX for the treatment of the psychotic features of psychotic major depression, which is in Phase III clinical trials. Corcept Therapeutics Incorporated was co-founded by Alan Schatzberg and Joseph K. Belanoff. The company was incorporated in 1998 and is based in Menlo Park, California.